在健康参与者中,急性梅斯卡林的安全药理学
Aaron Klaiber1,2,3,4, Mélusine Humbert-Droz1,2,3,4, Laura Ley1,2,3,4
1Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.
British journal of clinical pharmacology
|November 26, 2024
概括
在临床试验中,高达800mg的单剂梅斯卡林在健康人群中似乎是安全的. 这项研究为心理健康状况的潜在迷幻疗法提供了关键的安全数据.
科学领域:
- 心理药理学 心理药理学
- 临床心理学 临床心理学
- 神经科学是一个神经科学.
背景情况:
- 迷幻药,包括梅斯卡林,在治疗抑郁和焦虑方面表现有前途.
- 对于梅斯卡林的治疗用途,安全性数据有限.
研究的目的:
- 评估单次口服剂量梅斯卡林的安全性和耐受性.
- 在受控环境中评估梅斯卡林的急性心理和身体影响.
主要方法:
- 两个双盲,随机,安慰剂对照研究的综合分析.
- 在48名健康参与者中,给予96次梅斯卡林 (100-800毫克).
- 对主观,自主和不良影响的监测,以及血液检查和"闪回".
主要成果:
- 积极的主观影响随剂量增加而增加,并且超过负面影响.
- 自主活动中适度增加;没有严重的血压升高.
- 恶心是剂量限制的;肝/功能和血液细胞计数保持正常.
- 在2%的管理中报告了"闪回".
结论:
- 在受控的临床环境中,高达800mg的单次梅斯卡林剂量是安全的.
- 在健康的参与者中没有观察到明显的急性心理或身体伤害.
- 根据安全概况,对梅斯卡林治疗潜力的进一步研究是有必要的.
更多相关视频
06:06Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
Published on: February 5, 2018
24.6K
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
10.9K
相关概念视频
Hallucinogens and Psychedelics
156
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
156
CNS Stimulants: Psychedelic Agents
127
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
127
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
84
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
84
